Genuine Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
- Revenue Growth 15.34%
- Profit Growth 30.77%
- Ebitda 155.25%
- Net Worth 69.69%
- Total Assets 4.75%
About Genuine Diagnostics
Genuine Diagnostics Private Limited (GDPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 July 2020 (Four years and six months 24 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 M.
Rahul Shukla and Pushpa Tiwari serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100MH2020PTC342870
- Company No.
342870
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Genuine Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Shukla  | Director | 29-Jul-2020 | Current |
| Pushpa Tiwari | Director | 29-Jul-2020 | Current |
Financial Performance of Genuine Diagnostics.
Genuine Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.34% increase. The company also saw a substantial improvement in profitability, with a 30.77% increase in profit. The company's net worth Soared by an impressive increase of 69.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genuine Diagnostics?
Unlock access to Genuine Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Genuine Path LlpRahul Shukla and Pushpa Tiwari are mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2022 | Canara Bank | ₹0.50 M | Open |
| 21 May 2022 | Canara Bank | ₹1.50 M | Open |
How Many Employees Work at Genuine Diagnostics?
Genuine Diagnostics has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genuine Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genuine Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.